Summary
Twenty-eight patients (12M, 16F) with insomnia were treated with nitrazepam 5 mg/d and oxazepam 25 mg/d, each for 11 days, in a double-blind crossover comparison with placebo. Half the patients received nitrazepam in the first drug period, and oxazepam in the second and the other half followed the contrary sequence.
Both nitrazepam and oxazepam were found to be effective in inducing sleep and increasing sleep quality. No effects on dreaming or adverse effects were found. Nitrazepam did influence the frequency of awakening, but only in the second drug period. In the first period it reduced self-waking.
It is concluded that both nitrazepam and oxazepam were effective in inducing sleep and in improving sleep quality.
Similar content being viewed by others
References
Bixler EO, Kales A, Soldatos CR, Kales JD, Healy B (1979) Prevalence of sleep disorders in the Los Angles metropolitan area. Am J Psychiat 136: 1257–1262
Karacan I, Thornby JI, Anch AM (1979) Prevalence of sleep disturbances in a primarily urban Florida county. Soc Sci Med 10: 239–244
Mellinger GD, Balter MB, Uhlenhuth EH (1985) Insomnia and its treatment: Prevalence and correlates. Arch Gen Psychiat 42: 225–232
Kales A, Kales JD (1984) Evaluation and Treatment of Insomnia. Oxford University Press, New York
Nicholson AN (1986) Hypnotics. Their place in therapeutics. Drugs 31: 164–176
Feinberg I, Fein G, Walker J (1977) Flurazepam effects on slow-wave sleep: Stage 4 suppressed but number of delta waves constant. Science 198: 847–848
Roehrs T, Zorick F, Kaffeman M, Sickelsteel J, Roth T (1982) Flurazepam for short-term treatment of complaint of insomnia. J Clin Pharmacol 22: 290–296
Lehmann W (1978) The effect of oxazepam on sleep in normal human volunteers. Acta Psychiat Scand [Suppl] 274: 33–39
Freemon FR, Al-Marashi MSH, Lee JCM (1977) The effect of a new bezodiazepine on the polygraphically monitored sleep of normal volunteers. J Clin Pharmacol 17: 398–401
Moric CM, Kwentus JA (1988) Area review: Sleep disorders. Behavioral and pharmacological treatments for insomnia. Ann Behav Med 10: 91–100
Kales A, Bixler EO, Kales JD, Scharf MB (1977) Comparative effectiveness of nine hypnotic drugs: Sleep laboratory studies. J Clin Pharmacol 17: 207–213
Wheatley D (1988) New hypnotic agents: Clinical studies in general practice. Pharm Biochem Behav 29: 811–813
Rickels K (1984) Clinical trials of hypnotics. J Clin Psychopharmacol 3: 133–139
Food and Drug Administration, US Department of Health (1977) Guidelines for the clinical evaluation of hypnotic drugs
Kirk RE (1968) Experimental design: procedures for the behavioral sciences. Belmont CA. Brooks/Cole.
Allen RP, Mendels J, Nevins DB, Chernik DA, Hoddes E (1987) Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months. J Clin Pharmacol 17: 768–775
Altamura AC, Colacurcio F, Mauri MC, De Vanna M, Rigamonti R, Maj M, Veltro F (1989) Studio clinico controllato dell'effeto del quazepam vs. triazolam in pazienti con disturbi del sonno. Minerva Psichiat 30: 159–164
Hezelbach-Feller DAC, Tshopp JM, Christeller S, Fabre J (1988) Comparison of the short-acting benzodiazepines midazolam and triaozolam with placebo. Arzneim-Forsch/Drug Res 38: 387–392
Ankier ST, Goa KL (1988) Quazepam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in insomnia. Drugs 35: 42–62
Tham TCK, Brown H, Taggart H McA (1989) Temazepam withdrawal in elderly hospitalized patients: A double blind randomized trial comparing abrupt versus gradual withdrawal. In J Med Sci 158: 295–296
Author information
Authors and Affiliations
Additional information
This study was in part supported by NATO (project no. RG. 0029/88)
Rights and permissions
About this article
Cite this article
Götestam, K.G., Oppöyen, F. & Berntzen, D. Treatment of insomnia with two benzodiazepines: a double-blind crossover study. Eur J Clin Pharmacol 41, 137–140 (1991). https://doi.org/10.1007/BF00265906
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265906